Tyler Ballweg1, Marissa White1, Margaret Parker1, Cameron Casey1, Amber Bo1, Zahra Farahbakhsh1, Austin Kayser1, Alexander Blair1, Heidi Lindroth2, Robert A Pearce1, Kaj Blennow3, Henrik Zetterberg4, Richard Lennertz1, Robert D Sanders5. 1. Department of Anesthesiology, University of Wisconsin, Madison, WI, USA. 2. Department of Medicine, Indiana University School of Medicine, Center for Aging Research, Center for Health Innovation and Implementation, Indianapolis, IN, USA. 3. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. 4. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK; UK Dementia Research Institute at UCL, London, UK. 5. University of Sydney, Sydney, NSW, Australia; Department of Anaesthetics, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. Electronic address: robert.sanders@sydney.edu.au.
Abstract
BACKGROUND: Postoperative delirium is associated with increases in the neuronal injury biomarker, neurofilament light (NfL). Here we tested whether two other biomarkers, glial fibrillary acidic protein (GFAP) and tau, are associated with postoperative delirium. METHODS: A total of 114 surgical patients were recruited into two prospective biomarker cohort studies with assessment of delirium severity and incidence. Plasma samples were sent for biomarker analysis including tau, NfL, and GFAP, and a panel of 10 cytokines. We determined a priori to adjust for interleukin-8 (IL-8), a marker of inflammation, when assessing associations between biomarkers and delirium incidence and severity. RESULTS: GFAP concentrations showed no relationship to delirium. The change in tau from preoperative concentrations to postoperative Day 1 was greater in patients with postoperative delirium (P<0.001) and correlated with delirium severity (ρ=0.39, P<0.001). The change in tau correlated with increases in IL-8 (P<0.001) and IL-10 (P=0.0029). Linear regression showed that the relevant clinical predictors of tau changes were age (P=0.037), prior stroke/transient ischaemic attack (P=0.001), and surgical blood loss (P<0.001). After adjusting for age, sex, preoperative cognition, and change in IL-8, tau remained significantly associated with delirium severity (P=0.026). Using linear mixed effect models, only tau (not NfL or IL-8) predicted recovery from delirium (P<0.001). CONCLUSIONS: The change in plasma tau was associated with delirium incidence and severity, and resolved over time in parallel with delirium features. The impact of this putative perioperative neuronal injury biomarker on long-term cognition merits further investigation. CLINICAL TRIAL REGISTRATION: NCT02926417 and NCT03124303.
BACKGROUND: Postoperative delirium is associated with increases in the neuronal injury biomarker, neurofilament light (NfL). Here we tested whether two other biomarkers, glial fibrillary acidic protein (GFAP) and tau, are associated with postoperative delirium. METHODS: A total of 114 surgical patients were recruited into two prospective biomarker cohort studies with assessment of delirium severity and incidence. Plasma samples were sent for biomarker analysis including tau, NfL, and GFAP, and a panel of 10 cytokines. We determined a priori to adjust for interleukin-8 (IL-8), a marker of inflammation, when assessing associations between biomarkers and delirium incidence and severity. RESULTS: GFAP concentrations showed no relationship to delirium. The change in tau from preoperative concentrations to postoperative Day 1 was greater in patients with postoperative delirium (P<0.001) and correlated with delirium severity (ρ=0.39, P<0.001). The change in tau correlated with increases in IL-8 (P<0.001) and IL-10 (P=0.0029). Linear regression showed that the relevant clinical predictors of tau changes were age (P=0.037), prior stroke/transient ischaemic attack (P=0.001), and surgical blood loss (P<0.001). After adjusting for age, sex, preoperative cognition, and change in IL-8, tau remained significantly associated with delirium severity (P=0.026). Using linear mixed effect models, only tau (not NfL or IL-8) predicted recovery from delirium (P<0.001). CONCLUSIONS: The change in plasma tau was associated with delirium incidence and severity, and resolved over time in parallel with delirium features. The impact of this putative perioperative neuronal injury biomarker on long-term cognition merits further investigation. CLINICAL TRIAL REGISTRATION: NCT02926417 and NCT03124303.
Authors: Elizabeth L Whitlock; L Grisell Diaz-Ramirez; Alexander K Smith; W John Boscardin; Michael S Avidan; M Maria Glymour Journal: Ann Thorac Surg Date: 2018-12-18 Impact factor: 4.330
Authors: Sharon K Inouye; Edward R Marcantonio; Cyrus M Kosar; Douglas Tommet; Eva M Schmitt; Thomas G Travison; Jane S Saczynski; Long H Ngo; David C Alsop; Richard N Jones Journal: Alzheimers Dement Date: 2016-04-18 Impact factor: 21.566
Authors: Chihiro Sato; Nicolas R Barthélemy; Kwasi G Mawuenyega; Bruce W Patterson; Brian A Gordon; Jennifer Jockel-Balsarotti; Melissa Sullivan; Matthew J Crisp; Tom Kasten; Kristopher M Kirmess; Nicholas M Kanaan; Kevin E Yarasheski; Alaina Baker-Nigh; Tammie L S Benzinger; Timothy M Miller; Celeste M Karch; Randall J Bateman Journal: Neuron Date: 2018-03-21 Impact factor: 17.173
Authors: Joost Witlox; Lisa S M Eurelings; Jos F M de Jonghe; Kees J Kalisvaart; Piet Eikelenboom; Willem A van Gool Journal: JAMA Date: 2010-07-28 Impact factor: 56.272
Authors: T Rappold; A Laflam; D Hori; C Brown; J Brandt; C D Mintz; F Sieber; A Gottschalk; G Yenokyan; A Everett; C W Hogue Journal: Br J Anaesth Date: 2016-01 Impact factor: 9.166
Authors: Kaoru Yamada; Jerrah K Holth; Fan Liao; Floy R Stewart; Thomas E Mahan; Hong Jiang; John R Cirrito; Tirth K Patel; Katja Hochgräfe; Eva-Maria Mandelkow; David M Holtzman Journal: J Exp Med Date: 2014-02-17 Impact factor: 14.307
Authors: Justin G Wu; Jennifer Taylor; Maggie Parker; David Kunkel; Cameron Rivera; Robert A Pearce; Richard Lennertz; Robert D Sanders Journal: Br J Anaesth Date: 2022-01-26 Impact factor: 9.166
Authors: David Kunkel; Margaret Parker; Cameron Casey; Bryan Krause; Robert A Pearce; Richard Lennertz; Robert D Sanders Journal: Br J Anaesth Date: 2021-09-29 Impact factor: 9.166
Authors: Jennifer Taylor; Margaret Parker; Cameron P Casey; Sean Tanabe; David Kunkel; Cameron Rivera; Henrik Zetterberg; Kaj Blennow; Robert A Pearce; Richard C Lennertz; Robert D Sanders Journal: Br J Anaesth Date: 2022-02-08 Impact factor: 11.719
Authors: Sophia Wang; Ryan Greene; Yiqing Song; Carol Chan; Heidi Lindroth; Sikandar Khan; Gabriel Rios; Robert D Sanders; Babar Khan Journal: Int Psychogeriatr Date: 2022-01-17 Impact factor: 7.191
Authors: Jennifer A Frontera; Allal Boutajangout; Arjun V Masurkar; Rebecca A Betensky; Yulin Ge; Alok Vedvyas; Ludovic Debure; Andre Moreira; Ariane Lewis; Joshua Huang; Sujata Thawani; Laura Balcer; Steven Galetta; Thomas Wisniewski Journal: Alzheimers Dement Date: 2022-01-13 Impact factor: 16.655
Authors: Ahmed Abdelhak; Matteo Foschi; Samir Abu-Rumeileh; John K Yue; Lucio D'Anna; Andre Huss; Patrick Oeckl; Albert C Ludolph; Jens Kuhle; Axel Petzold; Geoffrey T Manley; Ari J Green; Markus Otto; Hayrettin Tumani Journal: Nat Rev Neurol Date: 2022-02-03 Impact factor: 44.711
Authors: Sean Tanabe; Maggie Parker; Richard Lennertz; Robert A Pearce; Matthew I Banks; Robert D Sanders Journal: J Gerontol A Biol Sci Med Sci Date: 2022-03-03 Impact factor: 6.591
Authors: Margaret Parker; Marissa White; Cameron Casey; David Kunkel; Amber Bo; Kaj Blennow; Henrik Zetterberg; Robert A Pearce; Richard Lennertz; Robert D Sanders Journal: J Gerontol A Biol Sci Med Sci Date: 2022-03-03 Impact factor: 6.591